Alan List, MD
CEO & President, Moffitt Cancer Center
Acquired M.D. from University of Penn. Internationally known for many contributions in the development of novel, more effective treatment strategies for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
Kathy McGraw, Ph.D.
Acquired Ph.D. in Cancer Biology from the University of South Florida and B.S. in Microbiology and Cell Science from the University of Florida. Currently working on identifying genetic predispositions to Myelodysplastic Syndromes and the role of endoplasmic reticulum stress on disease pathogenesis.
Nicole Vincelette, Ph.D.
Acquired Ph.D. in Molecular Pharmacology and Experimental Therapeutics from Mayo Clinic College of Medicine and B.S. in Biology from the University of Northern Colorado. Currently working on identifying clinical drivers of MDS in the bone marrow microenvironment.
Amy McLemore, M.S.
Acquired M.S. in Biotechnology from Johns Hopkins University and B.S. in Biological Sciences from the University of Cincinnati. Currently studying immune checkpoint regulation in MDS patients as well as targeting AMPK as a novel therapeutic to treat these disorders.
Grace Ward, B.S.
Ph.D. Graduate Student
B.S. in Biology from the Ohio State University. Currently studying mitochondria function in MDS and the role of autophagy in disease pathogenesis.
Hsin-AN Hou, M.D., Ph.D.
International visiting Scholar
Acquired Ph.D. in Genetics of AML from the Graduate Institute of Clinical Medicine, National Taiwan University (NTU); M.D. from Chang-Shan Medical College, Taichung, Taiwan, and M.S. from Graduate Institute of Clinical Medicine, NTU. Currently working on studying the role of NLRP1 in MDS pathogenesis.
Undergraduate Research Intern
University of South Florida, assists in all laboratory projects
From Tampa, FL
Moffitt Team Member since 2006
Moffitt Team Member since 1988